Literature DB >> 18691180

ING1a expression increases during replicative senescence and induces a senescent phenotype.

Mohamed A Soliman1, Philip Berardi, Svitlana Pastyryeva, Paul Bonnefin, Xiaolan Feng, Ana Colina, Dallan Young, Karl Riabowol.   

Abstract

The ING family of tumor suppressor proteins affects cell growth, apoptosis and response to DNA damage by modulating chromatin structure through association with different HAT and HDAC complexes. The major splicing isoforms of the ING1 locus are ING1a and INGlb. While INGlb plays a role in inducing apoptosis, the function of ING1a is currently unknown. Here we show that alternative splicing of the ING1 message alters the INGla:INGlb ratio by approximately 30-fold in senescent compared to low passage primary fibroblasts. INGla antagonizes INGlb function in apoptosis, induces the formation of structures resembling senescence-associated heterochromatic foci containing heterochromatin protein 1 gamma, the accumulation of senescence-associated beta-galactosidase activity and promotes senescent cell morphology and cell cycle arrest. Phenotypic effects may result from differential effects on gene expression since ING1a increases levels of both retinoblastoma and the p16 cyclin-dependent kinase inhibitor and ING1a and ING1b have opposite effects on the expression of proliferating nuclear cell antigen (PCNA), which is required for cell growth. Gene expression appears to be altered by targeting of HDAC complexes to gene promoters since INGla associates with several-fold higher levels of HDAC1 in senescent, compared to replication-competent cells and ING1 is found on the PCNA promoter by chromatin immunoprecipitation analysis. These data demonstrate a novel role for the ING1 proteins in differentially regulating senescence-associated chromatin remodeling vs. apoptosis and support the idea that altered ratios of the ING1 splicing isoforms may contribute to establishing the senescent phenotype through HDAC and HAT complex-mediated effects on chromatin structure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691180     DOI: 10.1111/j.1474-9726.2008.00427.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  29 in total

Review 1.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

2.  A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.

Authors:  Mohsen Esmaeili; Thanakorn Pungsrinont; Andrea Schaefer; Aria Baniahmad
Journal:  J Mol Med (Berl)       Date:  2016-06-16       Impact factor: 4.599

Review 3.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

Review 4.  Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?

Authors:  S J Chinta; C A Lieu; M Demaria; R-M Laberge; J Campisi; J K Andersen
Journal:  J Intern Med       Date:  2013-05       Impact factor: 8.989

Review 5.  Role of HDAC1 in senescence, aging, and cancer.

Authors:  Danielle Willis-Martinez; Hunter W Richards; Nikolai A Timchenko; Estela E Medrano
Journal:  Exp Gerontol       Date:  2009-10-08       Impact factor: 4.032

Review 6.  Reviewing the current classification of inhibitor of growth family proteins.

Authors:  Motoko Unoki; Kensuke Kumamoto; Seiichi Takenoshita; Curtis C Harris
Journal:  Cancer Sci       Date:  2009-04-28       Impact factor: 6.716

Review 7.  Metabolism, longevity and epigenetics.

Authors:  Claudia Cosentino; Raul Mostoslavsky
Journal:  Cell Mol Life Sci       Date:  2013-03-07       Impact factor: 9.261

8.  The landscape and biological relevance of aberrant alternative splicing events in esophageal squamous cell carcinoma.

Authors:  Quanyou Wu; Yuan Zhang; Haiyin An; Wei Sun; Ruozheng Wang; Meng Liu; Kaitai Zhang
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

Review 9.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

10.  Src regulates the activity of the ING1 tumor suppressor.

Authors:  Lisa Yu; Satbir Thakur; Rebecca Yy Leong-Quong; Keiko Suzuki; Andy Pang; Jeffrey D Bjorge; Karl Riabowol; Donald J Fujita
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.